Menu
Currency
GWAS Study

A genome-wide association scan on the levels of markers of inflammation in Sardinians reveals associations that underpin its complex regulation.

Naitza S, Porcu E, Steri M et al.

22291609 PubMed ID
GWAS Study Type
6086 Participants
120 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

NS
Naitza S
PE
Porcu E
SM
Steri M
TD
Taub DD
MA
Mulas A
XX
Xiao X
SJ
Strait J
DM
Dei M
LS
Lai S
BF
Busonero F
MA
Maschio A
UG
Usala G
ZM
Zoledziewska M
SC
Sidore C
ZI
Zara I
PM
Pitzalis M
LA
Loi A
VF
Virdis F
PR
Piras R
DF
Deidda F
WM
Whalen MB
CL
Crisponi L
CA
Concas A
PC
Podda C
US
Uzzau S
SP
Scheet P
LD
Longo DL
LE
Lakatta E
AG
Abecasis GR
CA
Cao A
SD
Schlessinger D
UM
Uda M
SS
Sanna S
CF
Cucca F
Chapter II

Abstract

Summary of the research findings

Identifying the genes that influence levels of pro-inflammatory molecules can help to elucidate the mechanisms underlying this process. We first conducted a two-stage genome-wide association scan (GWAS) for the key inflammatory biomarkers Interleukin-6 (IL-6), the general measure of inflammation erythrocyte sedimentation rate (ESR), monocyte chemotactic protein-1 (MCP-1), and high-sensitivity C-reactive protein (hsCRP) in a large cohort of individuals from the founder population of Sardinia. By analysing 731,213 autosomal or X chromosome SNPs and an additional ∼1.9 million imputed variants in 4,694 individuals, we identified several SNPs associated with the selected quantitative trait loci (QTLs) and replicated all the top signals in an independent sample of 1,392 individuals from the same population. Next, to increase power to detect and resolve associations, we further genotyped the whole cohort (6,145 individuals) for 293,875 variants included on the ImmunoChip and MetaboChip custom arrays. Overall, our combined approach led to the identification of 9 genome-wide significant novel independent signals-5 of which were identified only with the custom arrays-and provided confirmatory evidence for an additional 7. Novel signals include: for IL-6, in the ABO gene (rs657152, p = 2.13×10(-29)); for ESR, at the HBB (rs4910472, p = 2.31×10(-11)) and UCN119B/SPPL3 (rs11829037, p = 8.91×10(-10)) loci; for MCP-1, near its receptor CCR2 (rs17141006, p = 7.53×10(-13)) and in CADM3 (rs3026968, p = 7.63×10(-13)); for hsCRP, within the CRP gene (rs3093077, p = 5.73×10(-21)), near DARC (rs3845624, p = 1.43×10(-10)), UNC119B/SPPL3 (rs11829037, p = 1.50×10(-14)), and ICOSLG/AIRE (rs113459440, p = 1.54×10(-08)) loci. Confirmatory evidence was found for IL-6 in the IL-6R gene (rs4129267); for ESR at CR1 (rs12567990) and TMEM57 (rs10903129); for MCP-1 at DARC (rs12075); and for hsCRP at CRP (rs1205), HNF1A (rs225918), and APOC-I (rs4420638). Our results improve the current knowledge of genetic variants underlying inflammation and provide novel clues for the understanding of the molecular mechanisms regulating this complex process.

4,694 Sardinian individuals

Chapter III

Study Statistics

Key metrics and study information

6086
Total Participants
GWAS
Study Type
Yes
Replicated
1,392 Sardinian individuals
Replication Participants
European
Ancestry
Italy
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.